Mice supplied with B. adolescentis, the dominant species in the human intestine, showed reduced hepatic FGF21 levels, which were believed as an improvement of the non-alcoholic fatty liver disease (NAFLD)-related FGF21 resistance state 60. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.